|
|
Volumn 8, Issue 1, 2007, Pages 2-3
|
|
Combination of chemotherapy and immunotherapy for cancer: a paradigm revisited
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CANCER VACCINE;
CARBOPLATIN;
CYTOCHROME P450 1B1;
DENDRITIC CELL VACCINE;
DOCETAXEL;
PACLITAXEL;
PEPTIDE DERIVATIVE;
PROSTATE SPECIFIC ANTIGEN;
PROTEIN P53;
TOPOTECAN;
ADVANCED CANCER;
ANTINEOPLASTIC ACTIVITY;
CANCER CHEMOTHERAPY;
CANCER IMMUNIZATION;
CANCER IMMUNOTHERAPY;
CANCER RADIOTHERAPY;
CANCER RECURRENCE;
CANCER SURVIVAL;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
CYTOTOXIC T LYMPHOCYTE;
DRUG POTENTIATION;
DRUG RESPONSE;
GLIOMA;
HUMAN;
IMMUNOREACTIVITY;
LETTER;
LUNG SMALL CELL CANCER;
METASTASIS;
MONOTHERAPY;
OVERALL SURVIVAL;
PRIORITY JOURNAL;
PROSTATE CANCER;
RECURRENCE RISK;
SALVAGE THERAPY;
SOLID TUMOR;
SURVIVAL TIME;
TREATMENT FAILURE;
TUMOR IMMUNITY;
ANTINEOPLASTIC AGENTS;
COMBINED MODALITY THERAPY;
HUMANS;
IMMUNOTHERAPY;
NEOPLASMS;
|
|
EID: 33845646331
PISSN: 14702045
EISSN: None
Source Type: Journal
DOI: 10.1016/S1470-2045(06)70985-8 Document Type: Letter |
|
Times cited : (66)
|
|
References (6)
|
